New-money capital needs cut by >$30M
Company: Core Scientific
The claim, verbatim
The company says the Bitmain Transaction and the Celsius Settlement will reduce its new-money capital needs by more than $30 million. The Celsius Settlement alone accounts for about $18.5 million of that.
Source (primary)
core-scientific 8-K exhibit (d509828dex992.htm) (SEC EDGAR (8-K Ex), press_release)
View cached copy (2026-11-20)Live source ↗
Quote: “the Debtors will significantly reduce their new-money capital needs by more than $30 million through the Bitmain Transaction (as defined below) and the Celsius Settlement”
How we checked this
Checked on November 21, 2026. The cited source supports every part of this claim.
The document states that the two transactions together cut new-money capital needs by more than $30 million, with the Celsius Settlement contributing about $18.5 million.
Confirmed in the source:
- The Bitmain Transaction and the Celsius Settlement will reduce new-money capital needs by more than $30 million
- The Celsius Settlement will account for an approximate $18.5 million reduction in new-money capital needs
What we did: Read our cached copy of SEC EDGAR (8-K Ex) (https://www.sec.gov/Archives/edgar/data/1839341/000119312523231176/d509828dex992.htm) in full (450,114 characters, retrieved November 20, 2026) and checked each assertion in the claim against it.
Additional evidence
confirms core-scientific 8-K exhibit (d509828dex992.htm)
Quote: “the Debtors will significantly reduce their new-money capital needs by more than $30 million through the Bitmain Transaction (as defined below) and the Celsius Settlement”